Center for Joint Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
Biomedical Analysis Center, Third Military Medical University, Chongqing, China.
Am J Sports Med. 2019 Aug;47(10):2316-2326. doi: 10.1177/0363546519856355. Epub 2019 Jun 24.
BACKGROUND: Recruitment of endogenous stem cells has been considered an alternative to cell injection/implantation in articular cartilage repair. PURPOSE: (1) To develop a cartilage tissue-engineering scaffold with clinically available biomaterials and functionalize the scaffold with an aptamer (Apt19s) that specifically recognizes pluripotent stem cells. (2) To determine whether this scaffold could recruit joint-resident mesenchymal stem cells (MSCs) when implanted into an osteochondral defect in a rabbit model and to examine the effects of cartilage regeneration. STUDY DESIGN: Controlled laboratory study. METHODS: The reinforced scaffold was fabricated by embedding a silk fibroin sponge into silk fibroin/hyaluronic acid-tyramine hydrogel and characterized in vitro. A cylindrical osteochondral defect (3.2 mm wide × 4 mm deep) was created in the trochlear grooves of rabbit knees. The rabbits were randomly assigned into 3 groups: Apt19s-functionalized scaffold group, scaffold-only group, and control group. Animals were sacrificed at 6 and 12 weeks after transplantation. Repaired tissues were evaluated via gross examination, histologic examination, and immunohistochemistry. RESULTS: In vitro, this aptamer-functionalized scaffold could recruit bone marrow-derived MSCs and support cell adhesion. In vivo, the aptamer-functionalized scaffold enhanced cell homing in comparison with the aptamer-free scaffold. The aptamer-functionalized scaffold group also exhibited superior cartilage restoration when compared with the scaffold-only group and the control group. CONCLUSION: The Apt19s-functionalized scaffold exhibited the ability to recruit MSCs both in vitro and in vivo and achieved a better outcome of cartilage repair than the scaffold only or control in an osteochondral defect model. CLINICAL RELEVANCE: The findings demonstrate a promising strategy of using aptamer-functionalized bioscaffolds for restoration of chondral/osteochondral defects via aptamer-introduced homing of MSCs.
背景:在关节软骨修复中,人们已经开始考虑通过招募内源性干细胞来替代细胞注射/植入。
目的:(1)用临床可用的生物材料开发一种软骨组织工程支架,并对支架进行功能化处理,使其能够与特异性识别多能干细胞的适体(Apt19s)结合。(2)确定这种支架在兔模型的骨软骨缺损中植入时是否能够招募关节间充质干细胞(MSCs),并研究软骨再生的效果。
研究设计:对照实验室研究。
方法:通过将丝素蛋白海绵嵌入丝素蛋白/透明质酸-酪氨酸水凝胶中,制备增强型支架,并进行体外特性研究。在兔膝关节滑车沟处制备直径 3.2mm×4mm 的圆柱形骨软骨缺损。将兔子随机分为 3 组:Apt19s 功能化支架组、支架组和对照组。移植后 6 周和 12 周处死动物。通过大体观察、组织学检查和免疫组织化学检查评估修复组织。
结果:体外实验中,这种适体功能化支架可以募集骨髓间充质干细胞并支持细胞黏附。体内实验中,与无适体支架相比,适体功能化支架增强了细胞归巢。与支架组和对照组相比,适体功能化支架组的软骨修复效果也更好。
结论:与支架单独使用或对照组相比,Apt19s 功能化支架在体外和体内均表现出招募 MSCs 的能力,并在骨软骨缺损模型中实现了更好的软骨修复效果。
临床相关性:研究结果表明,使用适体功能化生物支架通过引入 MSC 的适体归巢来修复软骨/骨软骨缺损是一种很有前途的策略。
Theranostics. 2025-1-1
Front Bioeng Biotechnol. 2024-5-10
Front Bioeng Biotechnol. 2024-1-25
Front Bioeng Biotechnol. 2023-5-17
Int J Mol Sci. 2023-1-19